Evidence map›Paper›PMID 32997990›Full record

ArticleCell reports2020

Actin R256 Mono-methylation Is a Conserved Post-translational Modification Involved in Transcription.

Ashok Kumar, Yuan Zhong, Amelie Albrecht, Pau Biak Sang, Adrian Maples, Zhenan Liu, Vinesh Vinayachandran, Rohit Reja, Chia-Fang Lee, Ashutosh Kumar and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Recent advances in nuclear actin research.Nucleus (Austin, Tex.) · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 2 countries.

Ashok KumarDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Yuan ZhongDepartment of Epigenetics and Molecular Carcinogenesis, Science Park Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 78957, USA.
Amelie AlbrechtDepartment of Epigenetics and Molecular Carcinogenesis, Science Park Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 78957, USA; The University of Texas M.D. Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Pau Biak SangDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Adrian MaplesDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Zhenan LiuDepartment of Physiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Vinesh VinayachandranCenter for Eukaryotic Gene Regulation, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA.
Rohit RejaCenter for Eukaryotic Gene Regulation, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA.
Chia-Fang LeeICMB Proteomics Facility, The University of Texas at Austin, Austin, TX 78712, USA.
Ashutosh KumarLaboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Kanagawa 230-0045, Japan.
Jiyuan ChenDepartment of Internal Medicine, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.
Jing XiaoDepartment of Epigenetics and Molecular Carcinogenesis, Science Park Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 78957, USA.
Bongsoo ParkCenter for Eukaryotic Gene Regulation, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA.
Jianjun ShenDepartment of Epigenetics and Molecular Carcinogenesis, Science Park Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 78957, USA.
Bin LiuDepartment of Epigenetics and Molecular Carcinogenesis, Science Park Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 78957, USA.
Maria D PersonICMB Proteomics Facility, The University of Texas at Austin, Austin, TX 78712, USA.
Kathleen M TrybusDepartment of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405, USA.
Kam Y J ZhangLaboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Kanagawa 230-0045, Japan.
B Franklin PughCenter for Eukaryotic Gene Regulation, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA.
Kristine E KammDepartment of Physiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Dianna M MilewiczDepartment of Internal Medicine, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.
Xuetong ShenDepartment of Epigenetics and Molecular Carcinogenesis, Science Park Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 78957, USA. Electronic address: xshen@mdanderson.org.
Prabodh KapoorDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA. Electronic address: pkapoo02@amgen.com.
The University of Texas MD Anderson Cancer Center · USPennsylvania State University · USRIKEN Center for Biosystems Dynamics Research · JPThe University of Texas Health Science Center at Tyler · USThe University of Texas at Austin · USThe University of Texas Health Science Center at Houston · USThe University of Texas Southwestern Medical Center · USUniversity of Vermont · US

Funding

Pathology and Molecular Imaging CoreP01HL110869 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2016
$10.4M
Promoter Regulation in Response to Environmental StressR01ES013768 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PUGH, B FRANKLIN · 2007 to 2019
$4.9M
Post-translational Modification of ActinR01GM093104 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHEN, XUETONG · 2010 to 2019
$2.8M
Function of Nuclear Actin and Actin Related ProteinsK22CA100017 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI SHEN, XUETONG · 2003 to 2005
$473k
NCI NIH HHS K22 CA100017NHLBI NIH HHS P01 HL110869NIEHS NIH HHS R01 ES013768NIGMS NIH HHS R01 GM093104
6 · The paper itself

Abstract

Nuclear actin has been elusive due to the lack of knowledge about molecular mechanisms. From actin-containing chromatin remodeling complexes, we discovered an arginine mono-methylation mark on an evolutionarily conserved R256 residue of actin (R256me1). Actin R256 mutations in yeast affect nuclear functions and cause diseases in human. Interestingly, we show that an antibody specific for actin R256me1 preferentially stains nuclear actin over cytoplasmic actin in yeast, mouse, and human cells. We also show that actin R256me1 is regulated by protein arginine methyl transferase-5 (PRMT5) in HEK293 cells. A genome-wide survey of actin R256me1 mark provides a landscape for nuclear actin correlated with transcription. Further, gene expression and protein interaction studies uncover extensive correlations between actin R256me1 and active transcription. The discovery of actin R256me1 mark suggests a fundamental mechanism to distinguish nuclear actin from cytoplasmic actin through post-translational modification (PTM) and potentially implicates an actin PTM mark in transcription and human diseases.

Indexed as

ActinsAnimalsHumansMethylationMiceProtein Processing, Post-TranslationalTranscription FactorsActinsTranscription Factorsactinactin PTMsarginine monomethylationINO80nuclear actinPRMT5TAADtranscription

Identifiers

PMID32997990
PMCPMC8860185
OpenAlexW3090398803

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.